SA
Sign upLog In

Amneal Pharmaceuticals Inc Class A (AMRX)

Long-Term Debt

$2.67B

Quarterly · Period ending: · USD

AMRX logo

AMRX Long-Term Debt

Latest reported$2.67B
AMRX Quarterly Long-Term Debt ($1.16B → $2.67B)
High-resolution chart · PNG

AMRX long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amneal Pharmaceuticals Inc Class A Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
2,670,340,000
2,675,002,000
2,714,898,000
2,664,253,000
2,246,486,999
2,241,957,000
2,252,884,000
2,263,640,000
2,273,493,000
2,517,164,000
2,522,899,000
2,682,176,000
2,692,257,000
2,708,038,000
2,740,496,000
2,750,826,000
2,767,598,000
2,819,861,000
2,841,492,000
2,868,003,000
2,906,265,000
2,877,654,000
2,941,349,000
2,915,118,000
2,927,252,000
2,932,452,000
2,732,982,000
2,734,777,000
2,744,476,000
2,754,053,000
2,669,681,000
2,675,108,000
2,719,745,000
1,392,187,000
1,395,261,000
1,399,052,000
0
1,160,487,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.